Skip to content

Markets Face Weeks of Uncertainty in Wait for Virus Answers

  • Scientists need time to assess risks posed by omicron strain
  • BCA sees elevated volatility, Goldman flags short-term hedges
Video player cover image
Omicron Risks Higher Inflation, Tighter Supplies: Bianco
Updated on

The fate of global markets now depends at least in part on laboratories around the world probing the omicron Covid-19 strain, potentially leaving investors with weeks of uncertainty in the wait for answers. 

The variant detected in Africa is described as highly worrying and international travel bans are proliferating. Scientists are analyzing whether it can evade inoculations and the severity of illness it causes. Vaccine maker BioNTech SE expects the first data within two weeks, initial findings that will help determine if a passing scare or bigger hit to global economic reopening looms.